Viewing Study NCT04793958

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:02 AM
Ignite Modification Date: 2026-03-09 @ 2:15 AM
Study NCT ID: NCT04793958
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-11
First Post: 2021-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
Sponsor: Mirati Therapeutics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Colorectal Cancer View
None Metastatic Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Colorectal Cancer View
None Colorectal Cancer Trial View
None Colorectal Carcinoma View
None Rectal Cancer View
None Colon Cancer View
None KRAS View
None KRAS G12C View
None RAS View
None Colorectal Adenocarcinoma View